Synergistic Activity of Imipenem in Combination with Ceftazidime/Avibactam or Avibactam against Non-MBL-Producing Extensively Drug-Resistant Pseudomonas aeruginosa

Extensively drug-resistant Pseudomonas aeruginosa (XDRPA) infection is a significant public health threat due to a lack of effective therapeutic options. New β-lactam-β-lactamase inhibitor combinations, including ceftazidime-avibactam (CZA), have shown a high resistance rate to XDRPA. This study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yulin, Zhao, Jiankang, Han, Jiajing, Fan, Yanyan, Xiong, Zhujia, Zou, Xiaohui, Li, Binbin, Liu, Xinmeng, Li, Ziyao, Lu, Binghuai, Cao, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045292/
https://www.ncbi.nlm.nih.gov/pubmed/35315696
http://dx.doi.org/10.1128/spectrum.02740-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045292/
https://www.ncbi.nlm.nih.gov/pubmed/35315696
http://dx.doi.org/10.1128/spectrum.02740-21

Ejemplares similares